Cap-Free, Hidden-Needle Onestep Lancing Pen Debuts in Spain--First Step of SteriLance's European Roll-out
Comunicato Precedente
Comunicato Successivo
What makes Onestep different
In a recent evaluation with 30 frequent testers, 92 % reported "little or no pain," while 87 % felt safer because they never saw the needle.
Market context
Spain is home to an estimated 5.1 million adults with diabetes, one of the highest prevalence rates in Europe. Low-pain, easy-to-use devices such as Onestep can help improve adherence to daily self-monitoring, a cornerstone of effective diabetes management.
Availability
Onestep and SoftSense are now on sale in Spain via select brick-and-mortar pharmacies and partner e-commerce sites. Broader retail and pharmacy distribution across additional EU markets will commence in the coming months.
Compliance & resources
Onestep and SoftSense are CE-MDR and ISO 13485 certified and engineered for frequent, home-based capillary sampling.
For more information about Onestep and to explore its features, visit:
https://en.sterilance.com/innovative_products/onestep-lancing-device.
For media or distribution enquiries, please contact: [email protected].
Photo - https://mma.prnewswire.com/media/2728413/image_5020157_8534348.jpg
View original content:https://www.prnewswire.co.uk/news-releases/cap-free-hidden-needle-onestep-lancing-pen-debuts-in-spainfirst-step-of-sterilances-european-roll-out-302502067.html
Ufficio Stampa
PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom




